Pursuing lower pharmacy costs
One of the largest drivers of rising healthcare costs is the growing use and increased price of prescription drugs. We have several initiatives underway to help control these costs.
Prescription savings program
MedsYourWay® is an integrated discount program available to many of our members across the country, and it’s one more way we are trying to bring prescription drug costs down. The program automatically provides members the lowest available price of applicable discount cards for eligible medications—no coupons or other cards needed.1 And those costs will count toward their deductibles.
In the pipeline
BCBSRI was one of the founding members of CivicaScript™, with a mission to bring affordable versions of high-priced generic medicines to members. CivicaScript will begin manufacturing and distributing three low-cost insulin products in 2024. Stay tuned.
New cell and gene therapy program
Founded by Blue Cross and Blue Shield companies, the Synergie Medication CollectiveSM focuses on improving affordability for drugs that are injected or infused by a healthcare professional, including cell and gene therapies, by purchasing on behalf of 100 million Americans.
Employers can benefit from the approach that Synergie uses in its new Cell & Gene+ offering:
- Ensure treatment is high quality and more affordable
- Obtain refunds from pharmaceutical manufacturers if therapies don’t deliver expected outcomes